Articles On Sienna Cancer Diagnostics (ASX:SDX)

INOVIQ Limited (ASX: IIQ) has announced the appointment of David Williams as a Non-Executive Director and Chairman Elect, effective from the Annual General Meeting (AGM) scheduled for 29 November 2023. Mr Williams will succeed Dr Geoffrey C...

According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W...

When it comes to cancer diagnostics, the ‘tried and trusted’ methods are often not the best ones, but merely the techniques clinicians are familiar with. For the ASX-listed INOVIQ (ASX:IIQ), the field is ripe for disruption and the company...

The BARD1 Life Sciences Limited (ASX: BD1) share price isn’t going anywhere on Thursday. In fact, the BARD1 share price has vanished completely from the ASX boards today. Where is the BARD1 share price? The good news is that nothing bad ha...

Australian medical technology companies Bard1 Life Sciences (ASX:BD1) and Sienna Cancer Diagnostics (ASX:SDX) have announced they will merge to create a new cancer...

Medical technology companies Bard1 Life Sciences (ASX: BD1) and Sienna Cancer Diagnostics (ASX: SDX) will stage a $23.7 million merger to create an Australian-based cancer diagnostics entity focused on addressing unmet needs in early cancer...

Yesterday, Stockhead reviewed the small caps that are devising treatments to fight cancer. There are also a handful of small caps that are seeking to help with diagnostics. In other words these small caps are either seeking to identify the...

29 Nov 2019 - Sienna Cancer Diagnostics (ASX:SDX) is set to raise $4.2 million before costs via a share placement and rights issue at 3.5 cents per share.

Australian health care sector is growing potentially by generating significant profits in a short period, and that is something the investors are also closely monitoring. Australia’s public healthcare system is one of the world’s best, join...

On Stockhead today: are semiconductors about to pick up again, California’s first pot cafe opens, biotech losers’ remarkable comeback, and angel investment firm Investible closes with $22m round. But first:   The day ahead Today the Austral...

Want to know when shares are coming out of escrow? We’ve been keeping tabs, so you don’t have to. Every two weeks, Stockhead takes a look at the small cap companies that are releasing shares that have been locked away in escrow. Escrow refe...

Sienna Cancer Diagnostics (ASX:SDX), a medical technology company developing and commercialising cancer-related tests, has been granted its first US patent covering its in-vitro diagnostic (IVD) test for hTERT.